Every body has the power to heal

Aroa is unlocking regenerative healing, accessability and affordability

Find out more

Reinforced Bioscaffolds

Reinforced Bioscaffolds combine the best of biologics and synthetics to address the current shortcomings in surgical ventral hernia repair solutions. Read more about Reinforced Bioscaffolds on the TelaBio website.

 

Find out more

better healing, every day, everywhere for everybody

Our focus is delivering better healing, everyday, everywhere for everybody. We strive to make a meaningful impact for patients, surgeons and clinicians. We deliver high quality, simple to…

Find out more

Our magic comes from the mix of people

People are everything at Aroa. They come to work every day with ideas and passions that fuel our business. And go home at the end…

Find out more

Latest news

Aroa Biosurgery appoints new Vice President, Commercial

Auckland, NZ. Aroa Biosurgery a New Zealand-headquartered, emerging global leader for tissue regeneration products used in complex wounds and soft tissue repair, has announced the appointment of a highly experienced U.S. based executive, Brad Adams, to the new position of Vice President, Commercial.

Aroa Chief Executive Brian Ward welcomed the appointment of Mr Adams, who brings 20-years of experience in the strategic sales and marketing of medical devices within the United States medical system.

Continue reading

Aroa Biosurgery grows into additional markets with positive outcomes from Canadian clinical study

Auckland, NZ. Aroa Biosurgery, the Auckland-based privately held tissue-regeneration company, has this week presented positive outcomes of a new clinical study in Canada performed using its core wound product Endoform Natural®, which is being launched in the Canadian market along with Endoform Antimicrobial® in October 2019.

Continue reading

Aroa Biosurgery posts maiden profit as it expands sales presence in U.S. and global markets

Auckland, NZ. Aroa Biosurgery has posted a modest profit for the FY18/19 year, a first for the Auckland-based, privately held tissue-regeneration company since its formation 10 years ago.

Chief Executive Brian Ward said the first-time push into profit would be welcome news for the company’s tight and supportive family of investors. It was achieved off the back of 118% revenue growth to $24.2 million

Continue reading